
Gold Stocks And Gold – Looking At The Forest
The market action suggests that the corrective upswing is maturing and likely about to end. How can we tell? Silver.Silver is outperforming today, while miners are no longer doing so. …
Read MoreThe market action suggests that the corrective upswing is maturing and likely about to end. How can we tell? Silver.Silver is outperforming today, while miners are no longer doing so. …
Read MoreImage Source: As the ranks of option strategy ETFs continue to grow, it’s interesting to see which strategies fund sponsors will pick to set their ETFs apart from the crowd. …
Read MoreImage courtesy of While Intuitive Machines (Nasdaq: ) and Rocket Lab USA (Nasdaq: ) took the , the industry is a rapidly evolving one. These companies specialize in satellite deployments, the …
Read More(Click on image to enlarge) ISM Services PMI came in well below expectations, coming in at 52.1 (street was expecting 55.7), and 3.9 points below October. Although any reading above …
Read MoreImage Source: As part of the weekly research here at The Acquirer’s Multiple we’re always interested in investing gurus who hold the same stocks that appear in our Acquirer’s Multiple …
Read MoreIt’s been nearly a month now since the Presidential election, and from the close on 11/5 through yesterday (11/3), 354 (71%) of stocks in the index have experienced gains and …
Read MoreImage Source: Bond or fixed income investors talk a lot about yield curves, but what is a yield curve and how can it be used in portfolio management? Generally speaking, …
Read MoreCommentary from Fed officials has leaned dovish over the past week, suggesting subdued data will give them greater confidence to cut rates at a third consecutive meeting on 18 December. This week’s …
Read MoreImage Source: Economic growth and added complexity sound like they would be good, but at some point, the combination gets to be too much–simplification is needed.Too much of the world’s …
Read MoreImage Source: On Wednesday, the FTSE 100, the leading stock index in the UK, fell, ending a consecutive five-day rally. The decline was largely attributed to a dip in AstraZeneca’s …
Read More